FDA.reportPublic FDA data

Vir Combination

Product NDC
43742-2040
11-digit product format
437422040
Labeler code
43742
Product ID
43742-2040_730cbe69-d67d-4041-bb71-46cc2829bcda
Type
HUMAN OTC DRUG
Nonproprietary name
Influenzinum (2021-2022), Herpes Simplex 1 Nosode, Herpes Simplex 2 Nosode, Human Herpesvirus 6A, Human Herpesvirus 6B, Cytomegalovirus Nosode, Hepatitis B Nosode, Adenoviren Nosode, Epstein-Barr Virus Nosode
Dosage form
LIQUID
Route
ORAL
Labeler
Deseret Biologicals, Inc.
Marketing category
UNAPPROVED HOMEOPATHIC
Marketing start
2022-02-02
Marketing end
2027-08-23
Substance
HEPATITIS B VIRUS; HUMAN ADENOVIRUS B SEROTYPE 7 STRAIN 55142 ANTIGEN; HUMAN ADENOVIRUS E SEROTYPE 4 STRAIN CL-68578 ANTIGEN; HUMAN HERPESVIRUS 1; HUMAN HERPESVIRUS 2; HUMAN HERPESVIRUS 4; HUMAN HERPESVIRUS 5; HUMAN HERPESVIRUS 6; INFLUENZA A VIRUS A/TASMANIA/503/2020 IVR-221 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/WASHINGTON/02/2019 ANTIGEN (FORMALDEHYDE INACTIVATED)
Active strength
33; 12; 12; 15; 15; 16; 18; 15; 12; 12; 12; 12 [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL
Pharmacologic classes
Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Live Human Adenovirus Type 4 Vaccine [EPC], Live Human Adenovirus Type 7 Vaccine [EPC], Vaccines, Adenovirus [Chemical/Ingredient], Vaccines, Adenovirus [Chemical/Ingredient], Vaccines, Live, Unattenuated [Chemical/Ingredient], Vaccines, Live, Unattenuated [Chemical/Ingredient]
NDC exclude flag
No
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
Vir Combination

Active Ingredients#

Ingredient, Strength table
IngredientStrength
INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED)33 [hp_X]/mL
INFLUENZA A VIRUS A/TASMANIA/503/2020 IVR-221 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED)12 [hp_C]/mL
INFLUENZA B VIRUS B/WASHINGTON/02/2019 ANTIGEN (FORMALDEHYDE INACTIVATED)12 [hp_C]/mL
INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED)15 [hp_X]/mL
HUMAN HERPESVIRUS 115 [hp_X]/mL
HUMAN HERPESVIRUS 216 [hp_C]/mL
HUMAN HERPESVIRUS 618 [hp_X]/mL
HUMAN HERPESVIRUS 515 [hp_X]/mL
HEPATITIS B VIRUS12 [hp_X]/mL
HUMAN ADENOVIRUS E SEROTYPE 4 STRAIN CL-68578 ANTIGEN12 [hp_X]/mL
HUMAN ADENOVIRUS B SEROTYPE 7 STRAIN 55142 ANTIGEN12 [hp_X]/mL
HUMAN HERPESVIRUS 412 [hp_X]/mL

Harmonized Identifiers#

Field, Values table
FieldValues
UniiWD5E5VYM2E, V529EJB2CX, VEH9U90EHX, B93BQX9789, 22G38P19RL, 74J6DNH49U, 4IX4VP35CR, 7COI029E6K, 77H9EM77P7, FKD3DUK39I, TM54L796SN, 2A26YW7PNX

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
43742-2040-1Vir Combination30 mL in 1 BOTTLE, DROPPERLIQUID303

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
43742-2040VIR COMBINATION (INFLUENZINUM (2021-2022), HERPES SIMPLEX 1 NOSODE, HERPES SIMPLEX 2 NOSODE, HUMAN HERPESVIRUS 6A, HUMAN HERPESVIRUS 6B, CYTOMEGALOVIRUS NOSODE, HEPATITIS B NOSODE, ADENOVIREN NOSODE, EPSTEIN-BARR VIRUS NOSODE) LIQUID [DESERET BIOLOGICALS, INC.]3Current NDC, Legacy NDC, 1 package rows20221209_b5275aba-df1f-4ee9-adcd-41021cf3df58.zip

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
43742-2040-14374220400130 mL in 1 BOTTLE, DROPPER (43742-2040-1) 30 ml2022-02-022027-08-23NoNoCurrent